Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAVE STUDY
NCT04962893Phase 2Completed
- Start
- Jun 2021
- Primary completion
- Jan 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of COVIBEL in coronavirus disease 2019 (COVID-19). Started Jun 2021; status: completed.
02
Drugs
COVIBEL
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04962893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04962893.